Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

Related Articles by Review for PubMed (Select 19581603)

1.

Association between statin-associated myopathy and skeletal muscle damage.

Mohaupt MG, Karas RH, Babiychuk EB, Sanchez-Freire V, Monastyrskaya K, Iyer L, Hoppeler H, Breil F, Draeger A.

CMAJ. 2009 Jul 7;181(1-2):E11-8. doi: 10.1503/cmaj.081785.

2.

Statin-induced myopathies.

Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ.

Pharmacol Rep. 2011;63(4):859-66. Review.

3.

Statin-associated myopathy.

Hamilton-Craig I.

Med J Aust. 2001 Nov 5;175(9):486-9. Review.

PMID:
11758079
4.

Statin-induced apoptosis and skeletal myopathy.

Dirks AJ, Jones KM.

Am J Physiol Cell Physiol. 2006 Dec;291(6):C1208-12. Epub 2006 Aug 2. Review.

5.

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.

Mohassel P, Mammen AL.

Muscle Nerve. 2013 Oct;48(4):477-83. doi: 10.1002/mus.23854. Epub 2013 Aug 30. Review.

PMID:
23519993
6.

Managing statin myopathy.

Venero CV, Thompson PD.

Endocrinol Metab Clin North Am. 2009 Mar;38(1):121-36. doi: 10.1016/j.ecl.2008.11.002. Review.

PMID:
19217515
7.

Statin intolerance.

Ahmad Z.

Am J Cardiol. 2014 May 15;113(10):1765-71. doi: 10.1016/j.amjcard.2014.02.033. Epub 2014 Mar 2. Review.

PMID:
24792743
8.

[Muscle problems due to statins: underestimated].

Janssen SP, Smulders YM, Gerdes VE, Visseren FL.

Ned Tijdschr Geneeskd. 2010;154:A1684. Review. Dutch.

PMID:
21435278
9.

Statin-associated myopathy and its exacerbation with exercise.

Meador BM, Huey KA.

Muscle Nerve. 2010 Oct;42(4):469-79. doi: 10.1002/mus.21817. Review.

PMID:
20878737
10.

Genetic predisposition to statin myopathy.

Vladutiu GD.

Curr Opin Rheumatol. 2008 Nov;20(6):648-55. doi: 10.1097/BOR.0b013e328314b7b4. Review.

PMID:
18946323
11.

Statin induced myopathy.

Sathasivam S, Lecky B.

BMJ. 2008 Nov 6;337:a2286. doi: 10.1136/bmj.a2286. Review. No abstract available.

PMID:
18988647
12.

Statin myopathy.

Radcliffe KA, Campbell WW.

Curr Neurol Neurosci Rep. 2008 Jan;8(1):66-72. Review.

PMID:
18367041
13.

A neuromuscular approach to statin-related myotoxicity.

Baker SK, Samjoo IA.

Can J Neurol Sci. 2008 Mar;35(1):8-21. Review.

PMID:
18380273
14.

Evidence-based management of statin myopathy.

Harper CR, Jacobson TA.

Curr Atheroscler Rep. 2010 Sep;12(5):322-30. doi: 10.1007/s11883-010-0120-9. Review.

PMID:
20628837
15.

Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators.

Whayne TF Jr.

Angiology. 2011 Jul;62(5):415-21. doi: 10.1177/0003319710395560. Epub 2011 Mar 18. Review.

PMID:
21421631
16.

The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.

Harper CR, Jacobson TA.

Curr Opin Lipidol. 2007 Aug;18(4):401-8. Review.

PMID:
17620856
17.

Managing the underestimated risk of statin-associated myopathy.

Rallidis LS, Fountoulaki K, Anastasiou-Nana M.

Int J Cardiol. 2012 Sep 6;159(3):169-76. doi: 10.1016/j.ijcard.2011.07.048. Epub 2011 Aug 2. Review.

PMID:
21813193
18.

The myopathy of statins.

Smogorzewski M.

J Ren Nutr. 2005 Jan;15(1):87-93. Review.

PMID:
15648014
19.

Clinical characterization and molecular mechanisms of statin myopathy.

Toth PP, Harper CR, Jacobson TA.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):955-69. doi: 10.1586/14779072.6.7.955. Review.

PMID:
18666846
20.

Considerations for safe use of statins: liver enzyme abnormalities and muscle toxicity.

Gillett RC Jr, Norrell A.

Am Fam Physician. 2011 Mar 15;83(6):711-6. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk